ARCHIVES

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

DCT Board Approves New Screening Program, Natural Product Concpets

March 1, 1985

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993